| 09:00-09:30 |
Guido Kroemer (Villejuif, France) |
| |
Immunogenic cell death for optimal anticancer chemotherapy |
| 09:30-10:00 |
Marja Jäättelä (Kopenhagen, Denmark) |
| |
Lysosomal acid sphingomyelinase as a target for cancer therapy |
| 10:00-10:30 |
Andreas Strasser (Victoria, Australia) |
| |
Which pro-survival Bcl-2 family members should be targeted for the treatment of different cancers? |
| |
|
| 10:30-11:00 |
Coffee (with exhibition viewing) |
| |
|
| 11:00-11:30 |
Gerry Melino (Rome, Italy) |
| |
Involvement of p73, a p53-family member, in metabolism and senescence |
| 11:30-11:45 |
Paolo Bonaldo (University of Padova, Italy) |
| |
Apoptosis and autophagy in muscular dystrophies linked to collagen VI deficiency |
| 11:45-12:00 |
Sarita Larisch (University of Haifa, Israel) |
| |
The pro-apoptotic ARTS protein initiates mitochondrial apoptosis upstream of MOMP and promotes the release cytochrome c and SMAC/Diablo |
| 12:00-12:30 |
Mauro Piacentini (Rome, Italy) |
| |
Ambra1 is a key regulatory element of the early and late stages of autophagy |
| 14:00-14:30 |
Jan Paul Medema (Amsterdam, The Netherlands) |
| |
Colon Cancer stem cells; their role in tumor growth and therapy resistance |
| 14:30-14:45 |
Selcuk Colak (Academic Medical Center, The Netherlands) |
| |
Inhibition of HDACs sensitizes chemotherapeutic resistant colon Cancer Stem Cells |
| 14:45-15:00 |
Jose L. Venero (Universidad de Sevilla, Spain) |
| |
A novel role for executioner caspases in controlling microglia activation and neurotoxicity |
| 15:00-15:30 |
Jesus Gil (London, UK) |
| |
Epigenetic control of the INK4/ARF locus |
| 15:30-16:00 |
Nicholas La Thangue (Oxford, UK) |
| |
HDAC inhibitors: from bench to clinic, and back again |
| |
|
Home 
